Interference of anaesthetics with radioligand binding in neuroreceptor studies
- 25 April 2003
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 30 (6) , 912-915
Abstract
Evaluations of new emission tomography ligands are usually carried out in animals. In order to keep the animals in a restricted position during the scan session, anaesthesia is almost inevitable. In ex vivo rat studies we investigated the interference of ketamine/xylazine, zoletile mixture, isoflurane and halothane with the serotonin re-uptake site, the serotonin2A receptor and the dopamine re-uptake site by use of [3H]-(S)-citalopram, [18F]altanserin and [125I]PE2I, respectively. Ketamine/xylazine decreased the target-to-background ratio (mean ± SD) of [3H]-(S)-citalopram from 1.5±0.19 to 0.81±0.19 (PP18F]altanserin. The [125I]PE2I target-to-background ratio decreased with both ketamine/xylazine (from 12.4±0.81 to 10.1±1.4, P P<0.05) treated rats, whereas treatment with zoletile mixture and halothane left the ratio unaltered. It is concluded that prior to performance of neuroreceptor radioligand studies, the possible interaction between radioligands and anaesthetics should be carefully evaluated.Keywords
This publication has 9 references indexed in Scilit:
- Predosing with the unlabeled “inactive” enantiomer as a tool for improvement of the PET signalSynapse, 2002
- Ketamine alters the availability of striatal dopamine transporter as measured by [11C]β‐CFT and [11C]β‐CIT‐FE in the monkey brainSynapse, 2001
- Anatomic and Biochemical Correlates of the Dopamine Transporter Ligand 11C-PE2I in Normal and Parkinsonian Primates: Comparison with 6-[18F]Fluoro-L-DopaJournal of Cerebral Blood Flow & Metabolism, 2001
- Evaluation of [O-methyl-(11)C]fluvoxamine as a tracer for serotonin re-uptake sites.Nuclear Medicine and Biology, 2000
- Exploration of the Dopamine Transporter: In Vitro and In Vivo Characterization of a High-Affinity and High-Specificity Iodinated Tropane Derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy- 3β-(4′-methylphenyl)nortropane (PE2I)Nuclear Medicine and Biology, 1998
- Inhibition of 5-Hydroxytryptamine Type 2A Receptor-Induced Currents by n-Alcohols and AnestheticsThe Journal of Pharmacology and Experimental Therapeutics, 1997
- Anesthetics block morphine‐induced increases in serotonin release in rat CNSSynapse, 1994
- Contrasting Neurochemical Interactions of Tiletamine, a Potent Phencyclidine (PCP) Receptor Ligand, with the N-Methyl-D-Aspartate-Coupled and -Uncoupled PCP Recognition SitesJournal of Neurochemistry, 1991
- The influence of isoflurane on the synaptic activity of 5-hydroxytryptamineNeurochemical Research, 1990